Articles by Ellen Kurek

Latest Articles

Wet AMD: Aflibercept Best at Reducing Severe Increases in Pigment Epithelial Detachment Height
  |  Ellen Kurek
Researchers compared aflibercept, bevacizumab, and ranibizumab injections.
This Is Why Patients Stop Adalimumab Treatment for JIA-Associated Uveitis
  |  Ellen Kurek
Despite good responses, patients dropped adalimumab treatment.
Infliximab Antibodies Formation Differs in Children with Uveitis, Refractory Arthritis
  |  Ellen Kurek
Researchers evaluated children with arthritis, uveitis, and both.
Adalimumab Effective for Uveitis Associated with Juvenile Idiopathic Arthritis
  |  Ellen Kurek
When standard treatment failed, adding adalimumab achieved remission in 64%.
Study: Monthly Aflibercept Showed Best Results for AMD Patients with Persistent Retinal Fluid
  |  Ellen Kurek
Of the 3 regimens, monthly aflibercept produced the greatest gain in mean BCVA.
Preventing “Sunset Glow” in Patients with Acute Uveitis from Vogt–Koyanagi–Harada Disease
  |  Ellen Kurek
A combination of mycophenolate mofetil and corticosteroid showed benefit.
Patients with Noninfectious Uveitis May Be Spared from AMD, Study Shows
  |  Ellen Kurek
Uveitis patients age ≥55 years are less likely to have large drusen than others.
Trial Examines Ranibizumab Injections and Vascular Pigment Epithelium Detachment in AMD Patients
  |  Ellen Kurek
Screen for morphological risk factors for an RPE tear before each injection.
New Ocular Toxoplasmosis Review: Cats Carry, Triple-Therapy Clears
  |  Ellen Kurek
T. gondii is one of the most common causes of infectious posterior uveitis.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$